The Health 2.0 grassroot movement is the perfect opportunity for the pharma industry to reinvent itself, go beyond their mission to develop and market new drugs, and be part of a more global and patient-centric approach to health care. This session not only explores tools producing data that fuel R&D but also showcases solutions that allow the pharma industry to further engage with patients and strengthen their collaboration with doctors.
Health 2.0 companies have brought in much needed tools to make navigating the Pharma industry easier. With complex databases allowing users greater transparency of drug costs and interactions, as well as new tools for increasing adherence, the world of Pharma is becoming increasingly more user friendly for both patients and doctors alike. Marc Southern of FleishmanHillard presented their research on authenticity and consumer expectation in Pharma followed by 5 companies doing work in Pharmaceutical media, tracking, adherence and more.
John is a self-proclaimed “social media evangelist” with background as a journalist and Internet start-up entrepreneur. He has over 17 years of media experience, 10 of them in digital. John is responsible for Boehringer Ingelheim’s global digital strategy and if you need more convincing of his expertise, just check out his twitter account, @JohnPugh.
This session not only touches on social media communications applied to pharma, it showcases products that allow the pharma industry to collaborate with doctors, engage with patients, and make the most of data produced from various sources. Health 2.0 for Pharma explores opportunities, discusses best practices to avoid potential pitfalls, and covers hands-on approaches that show a shift in the industry to an increasing “healthy outcomes” ecosystem.